Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

NCT03844750 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Metastatic Malignant Neoplasm in the Liver
Stage IV Colorectal Cancer AJCC v8
Stage IVA Colorectal Cancer AJCC v8
Stage IVB Colorectal Cancer AJCC v8
Stage IVC Colorectal Cancer AJCC v8

Interventions

PROCEDURE: Hepatectomy
BIOLOGICAL: Pembrolizumab
DRUG: Vactosertib

Sponsor

Chloe Atreya, MD, PhD

Collaborators

[object Object]
[object Object]